Ms Natasha Samaroo, BSN RN is a
Clinical Nurse Specialist based in Patchogue, New York. Ms Natasha Samaroo is licensed to practice in New York (license number 668336) and her current practice location is
116 Phyllis Dr, Patchogue, New York. She can be reached at her office (for appointments etc.) via phone at
(631) 335-5226.
NPI number for Ms Natasha Samaroo is 1568082527 and her current mailing address is 116 Phyllis Dr, Patchogue, New York. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1568082527.
Provider's Profile
| Full Name | Ms Natasha Samaroo |
|---|
| Gender | Female |
|---|
| Speciality | Clinical Nurse Specialist |
|---|
| Location | 116 Phyllis Dr, Patchogue, New York |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1568082527
- Provider Enumeration Date: 04/20/2020
- Last Update Date: 01/17/2023
Medical Identifiers
Medical identifiers for Ms Natasha Samaroo such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1568082527 | NPI | - | NPPES |
| 668336 | Medicaid | NY | |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 364S00000X | Clinical Nurse Specialist | 668336 (New York) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Natasha Samaroo is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Ms Natasha Samaroo, BSN RN
116 Phyllis Dr,
Patchogue, NY 11772-2936
Ph: (631) 335-5226 | Ms Natasha Samaroo, BSN RN
116 Phyllis Dr,
Patchogue, NY 11772-2936
Ph: (631) 335-5226 |
Reviews and Comments